Raymond J  Owens
Raymond J Owens
Потвърден имейл адрес: strubi.ox.ac.uk
Protein production and purification
Architecture et Fonction des Macromolécules Biologiques Vincentelli Renaud 4 ...
Nature methods 5 (2), 135-146, 2008
Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor–neutralizing therapy in patients with inflammatory bowel disease
NR West, AN Hegazy, BMJ Owens, SJ Bullers, B Linggi, S Buonocore, ...
Nature medicine 23 (5), 579-589, 2017
A versatile ligation-independent cloning method suitable for high-throughput expression screening applications
NS Berrow, D Alderton, S Sainsbury, J Nettleship, R Assenberg, ...
Nucleic acids research 35 (6), e45, 2007
Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
J Huo, A Le Bas, RR Ruza, HME Duyvesteyn, H Mikolajek, T Malinauskas, ...
Nature structural & molecular biology 27 (9), 846-854, 2020
Structure and functionality in flavivirus NS-proteins: perspectives for drug design
M Bollati, K Alvarez, R Assenberg, C Baronti, B Canard, S Cook, ...
Antiviral research 87 (2), 125-148, 2010
Neutralization of SARS-CoV-2 by destruction of the prefusion spike
J Huo, Y Zhao, J Ren, D Zhou, HME Duyvesteyn, HM Ginn, L Carrique, ...
Cell host & microbe 28 (3), 445-454. e6, 2020
Lysine methylation as a routine rescue strategy for protein crystallization
TS Walter, C Meier, R Assenberg, KF Au, J Ren, A Verma, JE Nettleship, ...
Structure 14 (11), 1617-1622, 2006
Glycoprotein structural genomics: solving the glycosylation problem
VT Chang, M Crispin, AR Aricescu, DJ Harvey, JE Nettleship, JA Fennelly, ...
Structure 15 (3), 267-273, 2007
CDR grafted anti-CEA antibodies and their production
JR Adair, MW Bodmer, A Mountain, RJ Owens
US Patent 5,877,293, 1999
The nsp9 replicase protein of SARS-coronavirus, structure and functional insights
G Sutton, E Fry, L Carter, S Sainsbury, T Walter, J Nettleship, N Berrow, ...
Structure 12 (2), 341-353, 2004
Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient
D Zhou, HME Duyvesteyn, CP Chen, CG Huang, TH Chen, SR Shih, ...
Nature structural & molecular biology 27 (10), 950-958, 2020
A procedure for setting up high-throughput nanolitre crystallization experiments. Crystallization workflow for initial screening, automated storage, imaging and optimization
TS Walter, JM Diprose, CJ Mayo, C Siebold, MG Pickford, L Carter, ...
Acta Crystallographica Section D: Biological Crystallography 61 (6), 651-657, 2005
A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses
TK Tan, P Rijal, R Rahikainen, AH Keeble, L Schimanski, S Hussain, ...
Nature communications 12 (1), 542, 2021
The crystal structure of IgE Fc reveals an asymmetrically bent conformation
T Wan, RL Beavil, SM Fabiane, AJ Beavil, MK Sohi, M Keown, RJ Young, ...
Nature immunology 3 (7), 681-686, 2002
Adhiron: a stable and versatile peptide display scaffold for molecular recognition applications
C Tiede, AAS Tang, SE Deacon, U Mandal, JE Nettleship, RL Owen, ...
Protein Engineering, Design & Selection 27 (5), 145-155, 2014
Recombinant protein expression and solubility screening in Escherichia coli: a comparative study
NS Berrow, K Büssow, B Coutard, J Diprose, M Ekberg, GE Folkers, ...
Acta Crystallographica Section D: Biological Crystallography 62 (10), 1218-1226, 2006
Affimer proteins are versatile and renewable affinity reagents
C Tiede, R Bedford, SJ Heseltine, G Smith, I Wijetunga, R Ross, ...
Elife 6, e24903, 2017
Structural and functional insights of RANKL–RANK interaction and signaling
C Liu, TS Walter, P Huang, S Zhang, X Zhu, Y Wu, LR Wedderburn, ...
The Journal of Immunology 184 (12), 6910-6919, 2010
Primary structure of the human, membrane‐associated Ca2+‐binding protein p68 a novel member of a protein family.
MR Crompton, RJ Owens, NF Totty, SE Moss, MD Waterfield, ...
The EMBO Journal 7 (1), 21-27, 1988
Recombinant antibodies and methods for their production in which surface residues are altered to cysteine residues for attachment of effector or receptor molecules
MW Bodmer, JR Adair, NR Whittle, AH Lyons, RJ Owens
US Patent 5,219,996, 1993
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20